Valmark Advisers Inc. Acquires 98,883 Shares of Quanterix Co. (NASDAQ:QTRX)

Valmark Advisers Inc. increased its holdings in Quanterix Co. (NASDAQ:QTRX - Free Report) by 88.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 210,878 shares of the company's stock after purchasing an additional 98,883 shares during the period. Valmark Advisers Inc. owned approximately 0.55% of Quanterix worth $2,242,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in QTRX. Portolan Capital Management LLC increased its holdings in shares of Quanterix by 31.4% during the third quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company's stock worth $32,668,000 after buying an additional 602,656 shares in the last quarter. Easterly Investment Partners LLC increased its holdings in shares of Quanterix by 26.5% during the third quarter. Easterly Investment Partners LLC now owns 876,133 shares of the company's stock worth $11,355,000 after buying an additional 183,387 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Quanterix by 2.2% during the third quarter. Geode Capital Management LLC now owns 858,667 shares of the company's stock worth $11,131,000 after buying an additional 18,231 shares in the last quarter. State Street Corp increased its holdings in shares of Quanterix by 2.2% during the third quarter. State Street Corp now owns 836,443 shares of the company's stock worth $10,840,000 after buying an additional 18,050 shares in the last quarter. Finally, Emerald Advisers LLC increased its holdings in shares of Quanterix by 5.6% during the third quarter. Emerald Advisers LLC now owns 719,217 shares of the company's stock worth $9,321,000 after buying an additional 38,230 shares in the last quarter. Institutional investors and hedge funds own 86.48% of the company's stock.

Quanterix Trading Down 2.9 %

Shares of QTRX traded down $0.23 during mid-day trading on Thursday, hitting $7.58. 387,377 shares of the company traded hands, compared to its average volume of 843,745. Quanterix Co. has a one year low of $7.49 and a one year high of $29.70. The business has a 50-day moving average of $9.65 and a 200 day moving average of $11.60. The stock has a market capitalization of $291.98 million, a price-to-earnings ratio of -7.15 and a beta of 1.33.

Quanterix (NASDAQ:QTRX - Get Free Report) last released its quarterly earnings results on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. As a group, analysts anticipate that Quanterix Co. will post -0.98 earnings per share for the current year.

Analyst Ratings Changes

Separately, TD Cowen raised their price objective on shares of Quanterix from $13.50 to $16.00 and gave the stock a "hold" rating in a report on Wednesday, November 13th.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.